Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Directorate Changes and Update on Strategy

23 Jul 2019 07:00

RNS Number : 3446G
mporium Group PLC
23 July 2019
 

Mporium Group plc

("Mporium", the "Company" or the "Group")

 

Directorate Changes and Update on Strategy

 

Board Changes

Mporium Group plc (AIM: MPM) is pleased to announce the appointment of Tom Smith as Chief Executive Officer to succeed Nelius De Groot, who will step down as Chief Executive Officer but remain with the Company as a Non-Executive Director until the end of August 2019.

 

Tom's appointment to the Board will be effective immediately. Tom has worked with the Mporium Group, and previously Fast Web Media, since January 2008. In this time, he has been responsible for the strategy and operations of the Group. Tom became Head of MporiumX on its launch in November 2018 and has been Managing Director of the Group since June 2019. This aligns with the Company's increasing strategic focus on the market opportunity for its MporiumX division.

 

The Company is also pleased to announce the appointment of Charles Pendred as Independent Non-Executive Chairman of the Company, also with immediate effect. Charles has over 35 years' experience in equity capital markets having previously worked at Montagu Loebl Stanley, Garban Securities and notably, the Head of ICAP Securities. Charles has over 20 years' experience as a Non-Executive Director and is currently Non-Executive Director of the Orwell Group, a technology company specialising in the banking cash management function.

 

In addition, as set out in the Notice of AGM sent to shareholders on 28 June 2019, Aiden Casey, Non-Executive Director, will not be standing for re-election at the AGM and will therefore cease to be a director of the Company following the AGM.

 

The Company intends to appoint an additional, Independent Non-Executive Director in due course and will make a further announcement when appropriate.

 

 

Strategy Update

The Company also provides an update regarding the restructuring of the Group and its areas of focus for new business going forward. The Company expects the restructuring plan for the Mporium business to complete by 31 July 2019.

 

Going forward, the Company has identified three high-growth, scalable areas in which the business will focus commercial attention:

·; High value customer acquisition within sports related markets such as streaming and betting

·; Lead generation for the consumer regulation claims market, such as Packaged Bank Accounts and other financial claims

·; The cost effective licensing of Mporium's IMPACT platform through a self-service offering that provides valuable real-time insight and activation capability, using proprietary signal data

 

 

Mporium's Chief Executive, Tom Smith, said:

"In recent months the Company has made encouraging progress with its restructuring activities and is now emerging with a revised and well-defined strategy. Moving forwards, the business will be narrowing its focus to specific areas, including the sports and consumer regulation sectors, using the pay-for-performance model that characterised the MporiumX division prior to the restructure.

 

"We have every confidence that our leaner business model will drive growth and, ultimately, deliver greater shareholder value, and I look forward to supporting and advising the business as we move into this exciting new phase." 

 

Enquiries

 

Mporium:

020 3841 8411

Tom Smith, Chief Executive Officer

 

 

 

finnCap:

020 7220 0500

Henrik Persson / Kate Bannatyne (Corporate Finance)

Andrew Burdis (Corporate Broking)

 

 

Yellow Jersey PR:

020 3004 9512

Tim Thompson / Annabel Atkins / Joseph Burgess 

 

 

 

 

Notes to editors

About Mporium

Mporium is a technology company delivering event-driven digital marketing. Mporium's proprietary technology enables advertisers, to identify and leverage moments when there are significant changes in the levels of consumer engagement. MporiumX is the performance-led moment marketing media trading division of Mporium Group.

 

Based in the UK, Mporium Group plc is quoted on AIM, the junior market of the London Stock Exchange plc.

www.mporium.com

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Regulatory Disclosures - Tom Smith

The following disclosures are required regarding Tom's appointment pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:

Full name and age: Thomas James Smith, aged 35

Beneficial shareholdings - Tom holds 1,062,705 Ordinary Shares representing approximately 0.1% of the Company's issued share capital. Tom also has 6,250,000 options over Ordinary Shares in the Company.

Current directorships and partnerships:

Datapowa Limited

Sport Sync Technologies Ltd

 

No other directorships and partnerships held over the last 5 years

 

No further disclosure is required under AIM Rule 17 and paragraph (g) to Schedule Two of the AIM Rules with respect to Tom Smith.

 

Regulatory Disclosures - Charles Pendred

The following disclosures are required regarding Charles' appointment pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:

Full name and age: Charles Graham Pendred, aged 65

Beneficial shareholdings - Charles holds 7,300,000 Ordinary Shares representing approximately 0.7% of the Company's issued share capital.

Current directorships and partnerships:

Orwell Group Holding Limited

Maxispan Limited

 

 

No other directorships and partnerships held over the last 5 years. Mr Pendred is recorded as a director of MF Global UK Limited in the register of companies at Companies House. Mr Pendred believes that he resigned from this position (in line with having resigned from a number of associated companies) over 5 years ago although, due to a clerical error, this has not been updated in the records.

 

No further disclosure is required under AIM Rule 17 and paragraph (g) to Schedule Two of the AIM Rules with respect to Charles Pendred.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAFXAALSNEAF
Date   Source Headline
6th Jun 20147:00 amRNSAGM Statement
23rd May 20147:00 amRNSContract wins
22nd May 20145:00 pmRNSCompletion of audit
21st May 20145:06 pmRNSAnnual General Meeting
13th May 20147:00 amRNSResults for year ended 31 December 2013
29th Apr 201411:30 amRNSNotice of results & new product launch
31st Mar 20147:00 amRNSTOTAL VOTING RIGHTS
21st Mar 20147:00 amRNSAgreement with Affiliate Window
12th Mar 20143:39 pmRNSDirector/PDMR Shareholding
11th Mar 20144:35 pmRNSBlock Admission Application
7th Mar 20147:00 amRNSNew Customer and Sector Wins
20th Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
17th Jan 201410:17 amRNSHoldings in Company
18th Dec 20137:00 amRNSFirst Day of Dealings
5th Mar 20107:00 amRNSOffer Update
5th Mar 20107:00 amRNSCompulsory Acquisition of Minster Shares
17th Feb 20107:14 amRNSBoard Changes, Issue of Deferred Consideration
17th Feb 20107:00 amRNSOffer Update
1st Feb 201012:50 pmRNSDirectorate Change
25th Jan 20105:51 pmRNSEPT Disclosure
20th Jan 201011:59 amRNSRule 8.3- Minster Pharmaceuticals PLC
14th Jan 20104:00 pmRNSPosting of Offer Document
14th Jan 20104:00 pmRNSPosting of Offer Document
13th Jan 20102:27 pmRNSRule 8.3- Minster Pharma PLC
4th Jan 20103:11 pmRNSAcquisition of Minster Pharmaceuticals
4th Jan 20103:11 pmRNSCash Offer
20th Nov 20097:00 amRNSInterim Results
21st Sep 20097:00 amRNSDirectorate Change
15th Sep 20093:31 pmRNSChange of Registered Office
14th Sep 20097:00 amRNSTonabersat at IHS Congress
23rd Jul 20097:00 amRNSSabcomeline Patent Filing
17th Jul 200910:39 amRNSDirector/PDMR Shareholding
6th Jul 20097:00 amRNSPublication of Aura Results
30th Jun 200911:30 amRNSResult of AGM
30th Jun 20097:01 amRNSAGM Statement
30th Jun 20097:00 amRNSRajinder Kumar Appointment
2nd Jun 20095:04 pmRNSAnnual Financial Report
29th May 200910:51 amRNSGrant of Share Option to Director
29th May 200910:47 amRNSDirector/PDMR Shareholding
28th May 20097:00 amRNSPreliminary Results
20th Apr 20097:00 amRNSKarl Keegan appointed CFO
17th Apr 20097:16 amRNSDirectorate Change
11th Feb 20093:39 pmRNSHolding(s) in Company
2nd Feb 20097:00 amRNSTempus Study Results
18th Dec 200811:52 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSUS Licensing Consultant
14th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSNotice of Interim Results
22nd Oct 20087:00 amRNSPositive Phase II Results
30th Jun 20087:00 amRNSSymposium at AHS Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.